Poland· PL-100443964
Aliflusin
A paracetamol, kombinationen, exkl. psycholeptika product containing paracetamolum + acidum ascorbicum + chlorphenamini maleas, registered in Poland by Natur Produkt Zdrovit Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Paracetamol, kombinationen, exkl. psycholeptika is registered in 13 of 19 countries.
Countries holding a registration under ATC N02BE51 (paracetamol, kombinationen, exkl. psycholeptika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Paracetamol, kombinationen, exkl. psycholeptika · ATC N02BE51
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Paracetamolum + Acidum ascorbicum + Chlorphenamini maleas
- Manufacturer
- Natur Produkt Zdrovit Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N02BE51
- ATC class
- Paracetamol, Kombinationen, exkl. Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991499945
- gtin05909991499952
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for paracetamol, kombinationen, exkl. psycholeptika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paracetamol, kombinationen, exkl. psycholeptika · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Paracetamol, kombinationen, exkl. psycholeptika in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDEHORSANNatur Produkt Zdrovit Sp. z o.o., Varšava
- FranceFLUSTIMEX, poudre pour solution buvable en sachetBIOGARAN
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Bulgaria · Aliflusin, Алифлузин
- Czechia · Dehorsan
- France · Fluvalux Adultes, Fluvalux Enfants
- Croatia · Lupocet Flu, Lupocet Flu Forte
- Italy · Pumilflu Influenza E Raffreddore
- Lithuania · Aliflusin
- Romania · Aliflusin, Bioflu Hot Drink
- Slovakia · Dehorsan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5b4f65f5-6683-4bf5-ab30-912fe3dde795 GET /v1/drugs/5b4f65f5-6683-4bf5-ab30-912fe3dde795?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki musujące",
"source": "urpl",
"strength": "500 mg + 200 mg + 4 mg",
"packaging": "05909991499945 ¦ OTC ¦ 147442\n20 tabl.\n05909991499952 ¦ OTC ¦ 147443\n10 tabl.",
"substance": "Paracetamolum 500 mg + Acidum ascorbicum 200 mg + Chlorphenamini maleas 4 mg",
"common_name": "Paracetamolum + Acidum ascorbicum + Chlorphenamini maleas",
"pl_product_id": "100443964",
"pozwolenie_nr": "27417",
"auth_procedure": "DCP",
"authorisation_validity": "2027-10-26"
}See everything about paracetamol, kombinationen, exkl. psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.